The glycerol-3-phosphate shuttle transfers electrons from cytosolic NADH to dihydroxyacetone phosphate (DHAP), forming glycerol-3-phosphate. An inner mitochondrial membrane enzyme then transfers these electrons to FAD, forming FADH₂. This FADH₂ then enters the electron transport chain at Complex II. Because this process generates FADH₂ instead of NADH, it bypasses Complex I, resulting in fewer protons being pumped and a lower ATP yield (~1.5 ATP) compared to the malate-aspartate shuttle.

The patient's symptoms are characteristic of Wernicke encephalopathy, caused by thiamine (vitamin B1) deficiency. Thiamine, in its active form thiamine pyrophosphate (TPP), is an essential cofactor for the α-ketoglutarate dehydrogenase complex. This enzyme catalyzes the conversion of α-ketoglutarate to succinyl-CoA. This complex, like the pyruvate dehydrogenase complex, requires five cofactors: TPP, lipoic acid, coenzyme A, FAD, and NAD⁺.

Pyruvate carboxylase is the most important anaplerotic ('filling up') enzyme. It catalyzes the irreversible carboxylation of pyruvate to form oxaloacetate. This reaction is particularly crucial in the liver during gluconeogenesis, as it provides the necessary oxaloacetate for both the citric acid cycle to continue and for the synthesis of glucose. Malate dehydrogenase (C) is a reversible step within the TCA cycle itself, not a net source of new intermediates.

This is a classic presentation of arsenic poisoning. Arsenic binds to sulfhydryl groups in lipoic acid, inactivating it. Lipoic acid is a required cofactor for both the pyruvate dehydrogenase (PDH) complex and the α-ketoglutarate dehydrogenase complex. Inhibition of PDH prevents the conversion of pyruvate to acetyl-CoA, shunting pyruvate towards lactate formation and causing a severe lactic acidosis.

Rotenone is a specific inhibitor of Complex I (NADH:ubiquinone oxidoreductase) of the electron transport chain. It blocks the transfer of electrons from NADH to coenzyme Q. This directly halts the proton pumping activity of Complex I, which in turn leads to a buildup of NADH (increasing the NADH/NAD⁺ ratio) and a decrease in overall oxygen consumption and ATP synthesis. It does not affect electron flow from FADH₂ (which enters at Complex II) nor does it uncouple the chain.

Oligomycin is an antibiotic that specifically inhibits ATP synthase (Complex V) by binding to its F₀ subunit and blocking the proton channel. This prevents protons from flowing back into the mitochondrial matrix, thus inhibiting ATP synthesis. Because ATP synthesis is tightly coupled to electron transport, the buildup of the proton gradient creates a back-pressure that also inhibits the electron transport chain and oxygen consumption.

High doses of salicylates (aspirin) act as uncoupling agents. They are lipid-soluble weak acids that can transport protons across the inner mitochondrial membrane, bypassing ATP synthase. This dissipates the proton motive force, uncoupling electron transport from ATP synthesis. The energy that would have been captured in ATP is instead released as heat, causing hyperthermia. The body attempts to compensate by increasing the rate of electron transport and oxygen consumption, which generates even more heat.

Thermogenin, also known as uncoupling protein 1 (UCP1), is a proton channel in the inner mitochondrial membrane of brown adipocytes. When activated, it allows protons that have been pumped into the intermembrane space to flow back into the matrix, bypassing ATP synthase. This uncouples oxidative phosphorylation, and the energy stored in the proton gradient is released as heat rather than being converted to ATP, thus warming the infant.

The urea cycle produces fumarate as a byproduct when argininosuccinate is cleaved to form arginine. This fumarate can then enter the citric acid cycle and be converted to malate by fumarase, and subsequently to oxaloacetate. This links the two cycles, allowing for the disposal of nitrogen from amino acid catabolism while regenerating intermediates that can be used for energy or gluconeogenesis. A deficiency in fumarase disrupts this link.

The first and rate-limiting step of heme synthesis is the formation of δ-aminolevulinic acid (ALA), catalyzed by the enzyme ALA synthase. This mitochondrial enzyme catalyzes the condensation of one molecule of glycine with one molecule of succinyl-CoA, which is an intermediate of the citric acid cycle. This illustrates another key role of the TCA cycle in providing building blocks for other molecules.